Product Information
CLOCORTOLONE PIVALATE 0.1% CRM is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $5.2105 per GM under NDC 51672416606. Its NADAC has been published 170 times since Nov 23, 2022.
FDA first approved this application on Apr 21, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.001 g/g
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672416606
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
7/23/2025
Active Ingredients
CLOCORTOLONE PIVALATEApproval Type
Generic (ANDA)
FDA Application
ANDA206370FDA Approved
4/21/2020
TE Code
AB
On Market Since
4/21/2020
Pharmacological Classes
Price Statistics
The NADAC for CLOCORTOLONE PIVALATE 0.1% CRM has been published 170 times since Nov 23, 2022, and over the history we have for it it has risen 31.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.2105 per GM |
|---|---|
| All-time high | $5.2116 (May 14, 2025) |
| All-time low | $2.8680 (May 22, 2024) |
| 52-week high | $5.2105 |
| 52-week low | $5.2105 |
| Median price | $3.9689 |
| Average price | $4.3020 |
| Largest weekly change | +18.5% (Jun 19, 2024) |
| Weeks tracked | 170 |
| Tracking since | Nov 23, 2022 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
+31.3%
5Y
N/A
All
+31.3%
Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clocortolone Pivalate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clocortolone Pivalate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOCORTOLONE PIVALATE 0.1% CRM?
The current National Average Drug Acquisition Cost (NADAC) for CLOCORTOLONE PIVALATE 0.1% CRM, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $5.2105 per GM (NDC 51672416606), effective Jul 15, 2026.
How has the price of CLOCORTOLONE PIVALATE 0.1% CRM changed over time?
Over the history we have for it, the NADAC for CLOCORTOLONE PIVALATE 0.1% CRM has risen 31.3%. It has been tracked across 170 weekly CMS publications since Nov 23, 2022.
What are the highest and lowest recorded NADAC prices for CLOCORTOLONE PIVALATE 0.1% CRM?
Since Nov 23, 2022, the NADAC for CLOCORTOLONE PIVALATE 0.1% CRM has ranged from a low of $2.8680 (May 22, 2024) to a high of $5.2116 (May 14, 2025), with a median of $3.9689 per GM.
Are there cheaper alternatives to CLOCORTOLONE PIVALATE 0.1% CRM?
No other NADAC-published product currently shares the active ingredient and strength of CLOCORTOLONE PIVALATE 0.1% CRM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLOCORTOLONE PIVALATE 0.1% CRM?
CLOCORTOLONE PIVALATE 0.1% CRM (NDC 51672416606) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.